Hims & Hers shares plunge 28% on concerns over weight loss business

Shares of Hims & Hers Health closed down 22% on Tuesday, a day after the telehealth company released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business. Hims & Hers reported $481 million in revenue for the quarter, up 95% from $246.6 million during the same … Read more

Athenahealth to offer Abridge’s AI scribe to its network of thousands of doctors

Athenahealth to offer Abridge’s AI scribe to its network of thousands of doctors

A doctor looks at an AI-generated clinical note. Courtesy of Athenahealth Health-care software vendor Athenahealth on Tuesday said it will offer Abridge’s artificial intelligence scribing tool to its network of more than 160,000 clinicians.  Athenahealth has developed an electronic health record, revenue cycle management tools and patient engagement tools for ambulatory care providers, which include … Read more

Hims & Hers Health (HIMS) Q4 earnings 2024

Hims & Hers Health (HIMS) Q4 earnings 2024

Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings and focused instead on the disappointing gross margin. Here’s how the company did, compared to analysts’ consensus estimates from LSEG: Earnings per share: 11 cents vs. 10 cents expected Revenue: $481 million vs. $470 million expected … Read more

Anne Wojcicki new offer to take 23andMe private for $74.7 million

Anne Wojcicki new offer to take 23andMe private for .7 million

Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023. Kelly Sullivan | Getty Images Entertainment | Getty Images 23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities … Read more

Hims & Hers shares fall after FDA says semaglutide no longer in shortage

Hims & Hers shares fall after FDA says semaglutide no longer in shortage

Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called … Read more

Innovaccer launches AI agents for doctors, hospitals to fix burnout

Innovaccer launches AI agents for doctors, hospitals to fix burnout

Innovaccer CEO Abhinav Shashank. Courtesy: Innovaccer As doctors and nurses face historic rates of burnout, Innovacer says artificial intelligence is here to help. The health-care data company on Monday announced a suite of AI agents that are designed to automate repetitive, “low-value” tasks for clinicians.  “We just don’t have enough capacity in the health system to … Read more